Home
About
Overview
Sharing Data
ORCID
Help
History (6)
Lymphatic Vessel Tumors
Phase 2 clinical trial of a recombinant adeno-associated viral vector expressing ?1-antitrypsin: interim results.
Splenomegaly
The death domain kinase RIP is essential for TRAIL (Apo2L)-induced activation of IkappaB kinase and c-Jun N-terminal kinase.
Synaptic loss in Alzheimer's disease and other dementias.
See All 6 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Synaptic loss in Alzheimer's disease and other dementias.
Hamos JE, DeGennaro LJ, Drachman DA. Synaptic loss in Alzheimer's disease and other dementias. Neurology. 1989 Mar; 39(3):355-61.
View in:
PubMed
subject areas
Adolescent
Adult
Aged
Aged, 80 and over
Alzheimer Disease
Child
Humans
Middle Aged
Neurofibrils
Synapses